Exclusive: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial
Quantum BioPharma signed an agreement with Thermo Fisher to initiate a Phase 2 clinical trial for its multiple sclerosis therapy, Lucid-MS.
Share
Why It Matters
Thermo Fisher is helping Quantum BioPharma test a new MS medicine. This shows Thermo Fisher believes in the drug and Quantum BioPharma is moving forward.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.